Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

19 Jan 2010 07:00

RNS Number : 7493F
BrainJuicer Group PLC
19 January 2010
 



Press release 

19 January 2010

BrainJuicer Group PLC

("BrainJuicer" or "the Group" or "the Company")

Trading Update

Profitable growth

Leading international online market researcher, BrainJuicer Group PLC, today gives the following update on trading ahead of its Preliminary Results for the financial year ended 31 December 2009 which will be announced on 9 March 2010.

Highlights:

 

·;  
Results expected to be in line with market expectations; profitable growth continues despite difficult market conditions and significant investment in product development, operations and technology
·;
Revenue up around 26% to approximately £11.7 million (2008: £9.3 million)
·;
Operating profit up by more than 25% to over £1.6 million (2008: £1.29 million)
·;
Strong financial position with cash up to around £2.3 million at 31 December 2009 (30 June 2009: £1.2m) and no debt
·;
Innovative ‘Juicy’ products grew 65% to over 60% of turnover [2008: 46%]
·;
Working with 11 of the world’s top 20 buyers of market research [9 in 2008]
·;
Both new offices, Switzerland and Germany achieved profitability in their first 18 months

BrainJuicer's reputation for innovation grew further in 2009 with revenue from the Group's strategically important 'Juicy' products making significant gains and now accounting for over 60% of the Group's revenue (2008: 46%). These products are being sold to some of the world's largest buyers of market research. In 2009 the Company's clients included 11 of the world's top 20 buyers of market research, up from 9 in 2008, and revenue from these clients grew by over 70%. Client satisfaction remains high with repeat business at around 80%.

Revenue increase was driven by continued strong progress in the US, growing at around 60%, and by very encouraging contributions from the new offices in Switzerland and Germany. The Company's  UK business recovered after a slow start to the year (revenue for the full year was around 2% lower), and Dutch revenue grew about 10%. Overall the Group achieved approximately 26% revenue growth (21% on a constant currency basis).

Operating profit is up by more than 25whilst having at the same time invested more than ever before in developing and validating productsin back-office operations and in the Company's software  platform. We believe this investment will drive future growth.

The Group has reached an agreement to acquire High Level Research Inc., its Canadian licencee, for a nominal sum This will be managed as a regional office within our North American business.

John KearonCEO of BrainJuicer, commented: "To have grown so strongly in a year when spending on market research seems to have declined for the first time in 25 years is a tremendous achievement and testament to the attraction of our innovative 'Juicy' products, expanded geographic footprint and talented researchers to our major multinational client base. Despite the dire economic conditions, we have continued to make significant investments.  Whilst many of the largest research agencies have apparently declined and retrenched during 2009, we continued to invest heavily in new and existing 'Juicy' products, enhancing the efficiency and scalability of our technology platform and expanding our geographic footprint. These investments will, we believe, enable us to secure the global and regional mandates which we need to fulfil our longer term ambitions.

"The Board is confident that in 2010 we can continue to grow our business through  further product  innovation and increasing our market share with major multinational customers."

An analyst presentation, given by John KearonCEO, and James Geddes, CFO, will be held at 9.30am on 9 March 2010 at Abchurch's office, 16th Floor, 125 Old Broad StreetLondonEC2N 1AR.

- Ends -

For further information, please contact:

BrainJuicer Group PLC

Tel: +44 (0) 20 7043 1000

John Kearon, Chief Executive Officer

john.kearon@brainjuicer.com

James Geddes, Chief Financial Officer

james.geddes@brainjuicer.com

Canaccord Adams

Tel: +44 (0) 20 7050 6500

Mark Williams / Henry Fitzgerald-O'Connor

www.canaccordadams.com

Media enquiries:

Abchurch Communications

Heather Salmond / Joanne Shears

Tel: +44 (0) 20 7398 7709

joanne.shears@abchurch-group.com

www.abchurch-group.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUWOWRROAAAAR
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.